FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients With Earlier Quantification of Minimal Residual Disease

PLoS ONE
Multidisciplinary
2013English

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia

Clinical Medicine Insights: Oncology
Oncology
2015English

Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight-Color Tube With Dried Antibody Reagents

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2019English

Blinatumomab in Acute Lymphoblastic Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Minimal Residual Disease in Childhood B Lymphoblastic Leukemia and Its Correlation With Other Risk Factors

Pakistan Journal of Medical Sciences
Medicine
2019English

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Neonatal Inflammatory Markers Are Associated With Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy